YALE UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1701-10-09
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.yale.edu
Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir
Not Applicable
Completed
- Conditions
- HIV Infections
- Interventions
- Drug: Buprenorphine, Tipranavir and ritonavir
- First Posted Date
- 2007-06-14
- Last Posted Date
- 2020-04-20
- Lead Sponsor
- Yale University
- Target Recruit Count
- 12
- Registration Number
- NCT00486330
- Locations
- 🇺🇸
Yale University School of Medicine AIDS Program, New Haven, Connecticut, United States
Anger Control Training for Youth With Tourette Syndrome
Not Applicable
Completed
- Conditions
- Oppositional Defiant DisorderTourette SyndromeADHDChronic Tic Disorder
- First Posted Date
- 2007-06-14
- Last Posted Date
- 2022-02-11
- Lead Sponsor
- Yale University
- Target Recruit Count
- 26
- Registration Number
- NCT00486551
- Locations
- 🇺🇸
Yale University School of Medicine, Child Study Center, New Haven, Connecticut, United States
Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers
- First Posted Date
- 2007-05-15
- Last Posted Date
- 2013-01-23
- Lead Sponsor
- Yale University
- Target Recruit Count
- 15
- Registration Number
- NCT00473720
- Locations
- 🇺🇸
Yale University, Comprehensive Cancer Center, New Haven, Connecticut, United States
Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism
Phase 3
Completed
- Conditions
- Alcohol DependenceSchizophrenia
- Interventions
- Drug: Placebo
- First Posted Date
- 2007-04-20
- Last Posted Date
- 2020-03-31
- Lead Sponsor
- Yale University
- Target Recruit Count
- 23
- Registration Number
- NCT00463346
- Locations
- 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States
Galantamine for Cognitive Deficits in Schizophrenia
Phase 2
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2007-04-20
- Last Posted Date
- 2007-12-12
- Lead Sponsor
- Yale University
- Target Recruit Count
- 21
- Registration Number
- NCT00463879
- Locations
- 🇺🇸
Connecticut Mental Health Center, Yale School of Medicine, New Haven, Connecticut, United States
Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma
Phase 2
Completed
- Conditions
- Bladder Cancer
- Interventions
- First Posted Date
- 2007-04-18
- Last Posted Date
- 2017-12-14
- Lead Sponsor
- Yale University
- Target Recruit Count
- 17
- Registration Number
- NCT00461851
- Locations
- 🇺🇸
Yale University, Comprehensive Cancer Center, New Haven, Connecticut, United States
Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer
Phase 2
Terminated
- Conditions
- Hormone-Sensitive Breast CancerBreast Cancer
- Interventions
- First Posted Date
- 2007-04-18
- Last Posted Date
- 2021-03-16
- Lead Sponsor
- Yale University
- Target Recruit Count
- 5
- Registration Number
- NCT00461773
- Locations
- 🇺🇸
Yale University, Yale Cancer Center, New Haven, Connecticut, United States
Emergency Physician Brief Interventions for Alcohol
Not Applicable
Completed
- Conditions
- Hazardous DrinkingHarmful Drinking
- Interventions
- Behavioral: Brief Negotiation Interview (BNI)Behavioral: Discharge Instructions
- First Posted Date
- 2007-03-05
- Last Posted Date
- 2020-03-30
- Lead Sponsor
- Yale University
- Target Recruit Count
- 500
- Registration Number
- NCT00443183
- Locations
- 🇺🇸
Yale University, New Haven, Connecticut, United States
Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants
Phase 1
Completed
- Conditions
- Neoplastic SyndromeNon-melanomatous Skin Cancer
- First Posted Date
- 2007-02-12
- Last Posted Date
- 2016-09-23
- Lead Sponsor
- Yale University
- Target Recruit Count
- 16
- Registration Number
- NCT00433485
The Effect of Protein Supplementation on Bone Health in Healthy Older Men and Women
Phase 1
Completed
- Conditions
- Bone ResorptionOsteoporosis
- Interventions
- Dietary Supplement: Whey protein supplementDietary Supplement: Placebo
- First Posted Date
- 2007-01-12
- Last Posted Date
- 2020-04-09
- Lead Sponsor
- Yale University
- Target Recruit Count
- 208
- Registration Number
- NCT00421408
- Locations
- 🇺🇸
University of Connecticut Health Center, Farmington, Connecticut, United States
🇺🇸Yale University, New Haven, Connecticut, United States